Single-pass albumin dialysis in a child aged six months with phenobarbital poisoning

Hasan Serdar Kıhtır1, Hamdi Murat Yıldırım1, Osman Yeşilbaş1

  • 1Clinic of Pediatrics, Division of Pediatric Intensive Care, Bakırköy Sadi Konuk Training and Research Hospital, İstanbul, Turkey.

Turk Pediatri Arsivi
|January 27, 2017
PubMed

Insights

Severe phenobarbital overdose in a child was successfully treated with single-pass albumin dialysis. This innovative approach shows promise for managing drug toxicities, especially those involving protein-bound substances.

Area of Science:

  • Pediatric Intensive Care
  • Clinical Toxicology
  • Nephrology

Background:

  • A six-month-old girl presented with resistant seizures and was discharged on phenobarbital and carbamazepine.
  • The patient was later hospitalized due to unresponsiveness and respiratory distress, indicating a severe phenobarbital overdose from incorrect administration.

Observation:

  • The overdose necessitated intensive care and consideration of extracorporeal removal methods.
  • Hemodialysis was initially considered, but single-pass albumin dialysis was chosen due to phenobarbital's high plasma protein binding.

Findings:

  • Single-pass albumin dialysis was performed using a manually prepared 1% albumin dialysate.
  • After 6 hours, blood phenobarbital levels decreased from >140 mcg/mL to 62 mcg/mL, with significant clinical improvement.

Implications:

  • This case represents the first report of phenobarbital overdose treated with single-pass albumin dialysis.
  • Single-pass albumin dialysis may be an effective treatment for intoxications involving highly protein-bound drugs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
103
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
996